Safety in parathyroid surgery: innovation in diagnostic and minimally invasive operations

Abstract

The main treatment method of primary and tertiary hyperparathyroidism is surgery. However, surgical interventions on the parathyroid glands can lead to formidable complications such as laryngeal paresis and hypocalcemia. With this background, a comprehensive study examined the effectiveness of modern methods of diagnosis and surgical treatment of hyperparathyroidism to increase the safety level in surgery of the thyroid gland. The results of a comprehensive examination and treatment of 53 patients with hyperparathyroidism who underwent surgery using three methods were analyzed: traditional (n = 18/34); minimally invasive endoscopically assisted (n = 32/60), and endoscopic (transoral) (n = 3/6). Intraoperative neuromonitoring was also performed in all surgical interventions. Parathyroidectomy was performed under parathyroid monitoring for intraoperative topical diagnosis of parathyroid tumors in nine patients. The use of minimally invasive endoscopically assisted access to the parathyroid glands, as an alternative to the traditional approach, indicated that the preoperative potential in the diagnosis of parathyroid disorders. Moreover, intraoperative neuromonitoring and parathyroid monitoring demonstrated efficiency based on the decline in the incidence of specific postoperative complications with a tolerable increase in operative time, maintenance of the average duration of stationary treatment after surgery, and increased safety level of surgical treatment of hyperparathyroidism.

Keywords

surgery of the parathyroid glands / safety in surgery of the parathyroid glands / hyperparathyroidism / parathyroidectomy / minimally invasive parathyroidectomy / intraoperative neuromonitoring / intraoperative parathyroid monitoring

References

[1] Dedov II, Melnichenko GA, Mokrysheva NG, et al. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2016;62(6):40–77. (In Russ.) DOI: 10.14341/probl201662640-77

[2] Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г. и др. Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы лечения // Проблемы эндокринологии. 2016. Т. 62, № 6. С. 40–77. DOI: 10.14341/probl201662640-77

[3] Yu N, Donnan PT, Flynn RWV, et al. Increased mortality and morbidity in mild primary hyperparathyroid patients The Parathyroid Epidemiology and Audit Research Study (PEARS). Clinical Endocrinol (Oxf). 2010;73(1):30–33. DOI: 10.1111/j.1365-2265.2009.03766.x

[4] Yu N., Donnan P.T., Flynn R.W.V., et al. Increased mortality and morbidity in mild primary hyperparathyroid patients The Parathyroid Epidemiology and Audit Research Study (PEARS) // Clinical Endocrinol (Oxf). 2010. Vol. 73, No. 1. P. 30–33. DOI: 10.1111/j.1365-2265.2009.03766.x

[5] Romashchenko PN, Maistrenko NA, Krivolapov DS, et al. New standard of conclusiveness and safety in the parathyroid surgery. Grekov’s Bulletin of Surgery. 2020;179(1):58–62. (In Russ.) DOI: 10.24884/0042-4625-2020-179-1-58-62

[6] Ромащенко П.Н., Майстренко Н.А., Криволапов Д.С., и др. Новый уровень доказательности и безопасности в хирургии околощитовидных желез // Вестник хирургии им. И.И. Грекова. 2020. Т. 179, № 1. С. 58–62. DOI: 10.24884/0042-4625-2020-179-1-58-62

[7] Samohvalova NA, Maystrenko NA, Romashchenko PN. Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease. Grekov’s Bulletin of Surgery. 2013;172(2):43–46. (In Russ.) DOI: 10.24884/0042-4625-2013-172-2-043-046

[8] Самохвалова Н.А., Майстренко Н.А., Ромащенко П.Н. Программный подход к лечению вторичного гиперпаратиреоза при хронической болезни почек // Вестник хирургии им. И.И. Грекова. 2013. Т. 172, № 2. С. 43–46. DOI: 10.24884/0042-4625-2013-172-2-043-046

[9] Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959–968. DOI: 10.1001/jamasurg.2016.2310

[10] Wilhelm S.M., Wang T.S., Ruan D.T., et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism // JAMA Surg. 2016. Vol. 151, No. 10. P. 959–968. DOI: 10.1001/jamasurg.2016.2310

[11] Bilezikian JP. Primary hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993–4004. DOI: 10.1210/jc.2018-01225

[12] Bilezikian J.P. Primary hyperparathyroidism // J Clin Endocrinol Metab. 2018. Vol. 103, No. 11. P. 3993–4004. DOI: 10.1210/jc.2018-01225

[13] Jawaid I, Rajesh S. Hyperparathyroidism (primary) NICE guideline: diagnosis, assessment, and initial management. Br J Gen Pract. 2020;70(696):362–363. DOI: 10.3399/bjgp20X710717

[14] Jawaid I., Rajesh S. Hyperparathyroidism (primary) NICE guideline: diagnosis, assessment, and initial management // Br J Gen Pract. 2020. Vol. 70, No. 696. P. 362–363. DOI: 10.3399/bjgp20X710717

[15] Russell JO, Anuwong A, Dionigi G, et al. Transoral Thyroid and Parathyroid Surgery Vestibular Approach: A Framework for Assessment and Safe Exploration. Thyroid. 2018;28(7):825–829. DOI: 10.1089/thy.2017.0642

[16] Russell J.O., Anuwong A., Dionigi G., et al. Transoral Thyroid and Parathyroid Surgery Vestibular Approach: A Framework for Assessment and Safe Exploration // Thyroid. 2018. Vol. 28, No. 7. P. 825–829. DOI: 10.1089/thy.2017.0642

[17] Ryan S, Courtney D, Moriariu J, et al. Surgical management of primary hyperparathyroidism. European Archives of Oto-Rhino-Laryngology. 2017;274(12):4225–4232. DOI: 10.1007/s00405-017-4776-4

[18] Ryan S., Courtney D., Moriariu J., et al. Surgical management of primary hyperparathyroidism // European Archives of Oto-Rhino-Laryngology. 2017. Vol. 274, No. 12. P. 4225–4232. DOI: 10.1007/s00405-017-4776-4

[19] Romashchenko PN, Maistrenko NA, Krivolapov DS, et al. The radio navigation and photodynamic methods of parathyroid glands’ intraoperative visualisation (review of the literature). Grekov’s Bulletin of Surgery. 2020;179(3):113–119. (In Russ.). DOI: 10.24884/0042-4625-2020-179-3-113-119

[20] Ромащенко П.Н., Майстренко Н.А., Криволапов Д.С., и др. Радионавигационные и фотодинамические методики интраоперационной визуализации околощитовидных желез (обзор литературы) // Вестник хирургии им. И.И. Грекова. 2020. Т. 179, № 3. С. 113–119. DOI: 10.24884/0042-4625-2020-179-3-113-119

[21] De Leeuw F, Breuskin I, Abbaci M, et al. Intraoperative near-infrared imaging for parathyroid gland identification by autofluorescence: a feasibility study. World J Surg. 2016;40(9):2131–2138. DOI: 10.1007/s00268-016-3571-5

[22] De Leeuw F., Breuskin I., Abbaci M., et al. Intraoperative near-infrared imaging for parathyroid gland identification by autofluorescence: a feasibility study // World J Surg. 2016. Vol. 40, No. 9. P. 2131–2138. DOI: 10.1007/s00268-016-3571-5

[23] Chernykh AV, Maleev YuV, Shevtsov AN, et al. The prediction model features the topography of the parathyroid glands with the use of regression analysis. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2017;20(3):273–280. (In Russ.).

[24] Черных А.В., Малеев Ю.В., Шевцов А.Н., и др. Прогнозирование типовых особенностей топографии околощитовидных желез с применением регрессионного анализа // Таврический медико-биологический вестник. 2017. Т. 20, № 3. С. 273–280.

RIGHTS & PERMISSIONS

Romashchenko P.N., Maistrenko N.A., Vshivtsev D.O., Krivolapov D.S., Pryadko A.S.